Market Overview:
The Global Acute Care Diagnostic System Market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of chronic diseases, rising demand for point-of-care testing, and technological advancements in diagnostic systems. Based on type, the market is segmented into immunodiagnostics, chemistry diagnostics, molecular diagnostics, POCT (point-of-care testing), and other segments. Immunodiagnostics held the largest share of the global acute care diagnostic system market in 2017 and is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030. This segment is driven by factors such as rising prevalence of autoimmune diseases and growing demand for companion diagnostics tests. Based on application, hospitals accounted for majority share of global acute care diagnostic system market in 2017 and are projected to grow at a CAGR of 7%.
Product Definition:
An acute care diagnostic system is a computerized system used to manage and monitor the care of patients in an acute care setting. The system typically includes features that allow for the capture of patient data, tracking of treatment plans and orders, and monitoring of patient progress. The use of an acute care diagnostic system can help improve communication among caregivers, ensure that patients receive timely and appropriate treatment, and help to optimize patient outcomes.
Immuno Diagnostics:
The global immuno-diagnostics market is expected to grow at a lucrative rate during the forecast period. The key drivers of this market are increasing prevalence of chronic diseases and demand for rapid diagnostic tests. Moreover, growing awareness about early diagnosis and intervention along with supportive government initiatives is also fueling the growth of this industry.
Chemistry Diagnostics:
Chemistry diagnostic tests are used in the acute care diagnostic system market to provide information about a patient’s health. These tests help doctors and nurses understand the background of a patient, which helps them treat patients effectively.
Application Insights:
The others segment includes emergency rooms, urgent care centers, and walk-in clinics. The hospital segment dominated the market in 2017 owing to factors such as increasing prevalence of chronic diseases and rising geriatric population. Acute conditions require immediate medical attention and hence create a high demand for diagnostic systems in the hospitals.
The clinics application segment is anticipated to exhibit lucrative growth over the forecast period due to factors such as an increase in sports injuries requiring X-rays for diagnosis along with an increase in patients seeking treatment from general physicians or primary care physicians at clinics or walk-in centers. These factors are likely to drive acute care diagnostic system demand at outpatient facilities over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as favorable reimbursement policies, rising incidence of chronic diseases, and increasing healthcare expenditure. The U.S., which is at the forefront of this region, accounted for a revenue share of over 80% in 2017 owing to high R&D investments by companies operating within it and technological advancements made available there.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to improving healthcare infrastructure coupled with growing demand for cost-effective acute care diagnostic systems from emerging economies such as India and China along with other countries such as Indonesia & Malaysia & Vietnam etc.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. The rise in the number of people suffering from chronic diseases has led to a corresponding increase in demand for diagnostic services and treatment options. This, in turn, is driving growth in the Acute Care Diagnostic System market.
- Technological advancements: Rapid technological advancements are taking place across all industries, including healthcare. These advancements are resulting in innovative diagnostic systems that are more accurate and efficient than ever before. This is leading to increased demand for acute care diagnostic systems, thereby fuelling market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Acute Care Diagnostic System Market Research Report
By Type
Immuno Diagnostics, Chemistry Diagnostics, Molecular Diagnostics, POCT, Other
By Application
Hospitals, Clinics, Home Care, Others
By Companies
Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, Biomerieux, Ortho Clinical Diagnostics, Becton Dickinson, Bio-Rad Laboratories, Hologic, Johnson and Johnson, Qiagen, Myriad Genetics, Wondfo, KHB, DAAN Gene, Leadman Biochemistry, Mindray, BioSino
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
228
Number of Tables & Figures
160
Customization Available
Yes, the report can be customized as per your need.
Global Acute Care Diagnostic System Market Report Segments:
The global Acute Care Diagnostic System market is segmented on the basis of:
Types
Immuno Diagnostics, Chemistry Diagnostics, Molecular Diagnostics, POCT, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home Care, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Abbott
- Danaher
- Siemens Healthineers
- Thermo Fisher Scientific
- Sysmex
- Biomerieux
- Ortho Clinical Diagnostics
- Becton Dickinson
- Bio-Rad Laboratories
- Hologic
- Johnson and Johnson
- Qiagen
- Myriad Genetics
- Wondfo
- KHB
- DAAN Gene
- Leadman Biochemistry
- Mindray
- BioSino
Highlights of The Acute Care Diagnostic System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immuno Diagnostics
- Chemistry Diagnostics
- Molecular Diagnostics
- POCT
- Other
- By Application:
- Hospitals
- Clinics
- Home Care
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acute Care Diagnostic System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Acute Care Diagnostic System (ACDS) is a computerized system used to diagnose patients in the emergency department.
Some of the key players operating in the acute care diagnostic system market are Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, Biomerieux, Ortho Clinical Diagnostics, Becton Dickinson, Bio-Rad Laboratories, Hologic, Johnson and Johnson, Qiagen, Myriad Genetics, Wondfo, KHB, DAAN Gene, Leadman Biochemistry, Mindray, BioSino.
The acute care diagnostic system market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acute Care Diagnostic System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Acute Care Diagnostic System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Acute Care Diagnostic System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Acute Care Diagnostic System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Acute Care Diagnostic System Market Size & Forecast, 2018-2028
4.5.1 Acute Care Diagnostic System Market Size and Y-o-Y Growth
4.5.2 Acute Care Diagnostic System Market Absolute $ Opportunity
Chapter 5 Global Acute Care Diagnostic System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Acute Care Diagnostic System Market Size Forecast by Type
5.2.1 Immuno Diagnostics
5.2.2 Chemistry Diagnostics
5.2.3 Molecular Diagnostics
5.2.4 POCT
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Acute Care Diagnostic System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Acute Care Diagnostic System Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Home Care
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acute Care Diagnostic System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acute Care Diagnostic System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Acute Care Diagnostic System Analysis and Forecast
9.1 Introduction
9.2 North America Acute Care Diagnostic System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Acute Care Diagnostic System Market Size Forecast by Type
9.6.1 Immuno Diagnostics
9.6.2 Chemistry Diagnostics
9.6.3 Molecular Diagnostics
9.6.4 POCT
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Acute Care Diagnostic System Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Home Care
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Acute Care Diagnostic System Analysis and Forecast
10.1 Introduction
10.2 Europe Acute Care Diagnostic System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Acute Care Diagnostic System Market Size Forecast by Type
10.6.1 Immuno Diagnostics
10.6.2 Chemistry Diagnostics
10.6.3 Molecular Diagnostics
10.6.4 POCT
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Acute Care Diagnostic System Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Home Care
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Acute Care Diagnostic System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Acute Care Diagnostic System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Acute Care Diagnostic System Market Size Forecast by Type
11.6.1 Immuno Diagnostics
11.6.2 Chemistry Diagnostics
11.6.3 Molecular Diagnostics
11.6.4 POCT
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Acute Care Diagnostic System Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Home Care
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Acute Care Diagnostic System Analysis and Forecast
12.1 Introduction
12.2 Latin America Acute Care Diagnostic System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Acute Care Diagnostic System Market Size Forecast by Type
12.6.1 Immuno Diagnostics
12.6.2 Chemistry Diagnostics
12.6.3 Molecular Diagnostics
12.6.4 POCT
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Acute Care Diagnostic System Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Home Care
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Acute Care Diagnostic System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Acute Care Diagnostic System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Acute Care Diagnostic System Market Size Forecast by Type
13.6.1 Immuno Diagnostics
13.6.2 Chemistry Diagnostics
13.6.3 Molecular Diagnostics
13.6.4 POCT
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Acute Care Diagnostic System Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Home Care
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acute Care Diagnostic System Market: Competitive Dashboard
14.2 Global Acute Care Diagnostic System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Abbott
14.3.3 Danaher
14.3.4 Siemens Healthineers
14.3.5 Thermo Fisher Scientific
14.3.6 Sysmex
14.3.7 Biomerieux
14.3.8 Ortho Clinical Diagnostics
14.3.9 Becton Dickinson
14.3.10 Bio-Rad Laboratories
14.3.11 Hologic
14.3.12 Johnson and Johnson
14.3.13 Qiagen
14.3.14 Myriad Genetics
14.3.15 Wondfo
14.3.16 KHB
14.3.17 DAAN Gene
14.3.18 Leadman Biochemistry
14.3.19 Mindray
14.3.20 BioSino
